You have not yet added any article to your bookmarks!
Join 10k+ people to get notified about new posts, news and tips.
Do not worry we don't spam!
Post by : Shakul
India’s drug regulator has inspected nearly 90% of the country’s cough syrup manufacturers and found compliance lapses in some of them, officials said on Monday, amid increased scrutiny after India‑made syrups were linked to child deaths.
The inspections follow the discovery of a cough syrup brand called Coldrif, made by Sresan Pharmaceutical in Tamil Nadu, which was found to be contaminated with diethylene glycol and linked to the deaths of 24 children in October 2025.
Drugs Controller General of India Rajeev Raghuvanshi said the audits found issues such as poor manufacturing practices, failure to test incoming raw materials, and the use of improper processes at some facilities. He did not name specific companies that were non‑compliant.
India’s pharmaceutical industry, worth about $42 billion, is dominated by many small manufacturers, which has put pressure on regulators to improve oversight and quality standards.
To strengthen regulation, authorities plan to boost staffing, speed up approvals, and bring their operations closer to US Food and Drug Administration (FDA)‑level standards. The regulator also intends to use artificial intelligence to review applications and may bring in global industry experts for guidance.
Officials have also streamlined export clearances for drugs sent to major markets such as the United States, Europe, Australia, Japan, the UK, and Canada by removing the requirement for extra no‑objection certificates.
The inspections and enforcement actions come as part of a broader effort to restore confidence in India’s drug safety systems after toxic cough syrups caused deaths in India and abroad in recent years.
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
APEC members discuss responsible AI use, digital innovation and data governance as China and the US
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governa
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing
Singapore Warns Users About Privacy and Security Risks of AI Agents
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised acc
Chris Lynn Completes One-Month Ban After Positive Cocaine Test
Australian cricketer Chris Lynn completes a one-month ban after a positive cocaine test during the T
Djokovic Eyes Strong Season Finish as Health Improves Ahead of Paris Masters
Novak Djokovic reports improved health and performance as he targets a strong Paris Masters finish a